Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2016 Jan 1.

Published in final edited form as: J Hepatol. 2014 Sep 6;62(1):190–197. doi: 10.1016/j.jhep.2014.08.036

(A) Scatterplot and trend-line of adjusted MRI liver fat measurements at baseline and end-of-study. N-3 led to significant improvement in liver fat compared to placebo.

(B) Mean difference in pre to post-intervention change in MR-Liver-fat, between N-3 and placebo evaluated at the 1st, 2nd, and 3rd, quartiles of the pre to post-intervention change in body weight distribution. N-3 intervention appears to have greater effects in patients with lesser weight loss or weight gain.

(A) Scatterplot and trend-line of adjusted MRI liver fat measurements at baseline and end-of-study. N-3 led to significant improvement in liver fat compared to placebo.

(B) Mean difference in pre to post-intervention change in MR-Liver-fat, between N-3 and placebo evaluated at the 1st, 2nd, and 3rd, quartiles of the pre to post-intervention change in body weight distribution. N-3 intervention appears to have greater effects in patients with lesser weight loss or weight gain.